Cargando…
Pioglitazone use increases risk of Alzheimer's disease in patients with type 2 diabetes receiving insulin
Pioglitazone is an insulin resistance inhibitor widely used as monotherapy or combined with metformin or insulin in treating type 2 diabetes mellitus (T2DM). This study further investigated the relationship between pioglitazone use and the risk of developing Alzheimer's disease (AD) in patients...
Autores principales: | Lin, Hsin-Chung, Chung, Chi-Hsiang, Chen, Lih-Chyang, Wang, Jui-Yang, Chen, Chien-Chou, Huang, Kuo-Yang, Tsai, Ming-Hang, Chien, Wu-Chien, Lin, Hsin-An |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10126143/ https://www.ncbi.nlm.nih.gov/pubmed/37095270 http://dx.doi.org/10.1038/s41598-023-33674-2 |
Ejemplares similares
-
Association between trichomoniasis and prostate and bladder diseases: a population-based case–control study
por: Yang, Hung-Yi, et al.
Publicado: (2022) -
Infection with Trichomonas vaginalis increases the risk of psychiatric disorders in women: a nationwide population-based cohort study
por: Lin, Hsin-Chung, et al.
Publicado: (2019) -
Lactic Acid Fermentation Is Required for NLRP3 Inflammasome Activation
por: Lin, Hsin-Chung, et al.
Publicado: (2021) -
Patients receiving androgen deprivation therapy for prostate cancer have an increased risk of depressive disorder
por: Chung, Shiu-Dong, et al.
Publicado: (2017) -
Increased risk of sudden sensorineural hearing loss in patients with hepatitis virus infection
por: Chen, Hsin-Chien, et al.
Publicado: (2017)